http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220539-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a17fe980f18e014e78857381869fcec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df039a3bba404699e360a74b0bea24a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddd73f31f6b04300210aa01581405e43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_746eb112cb486f41fc1d207a639128bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_628226806b11938a2e8395f92b2469f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88dc228cb430cca8308c8a5ed1f606c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
filingDate 2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91e1e02f5ac192061483ee5e692c8b6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afa9c190e740c1bb905880c17485509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22844a4cf6f47322e1cea9ba75ab3b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f007aa470dfdbd67360f4c19d6945f7b
publicationDate 2002-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0220539-A1
titleOfInvention Adenosine derivatives and use thereof
abstract 2-(6-Cyano-1-hexyn-1-yl)adenosine, 2-(6-cyano-1-hexyn-1-yl)adenosine 5'-monophosphate or salts thereof and drugs containing the same as the active ingredient. The above-described compounds are excellent in the effect of lowering ocular tension and highly soluble in water. Therefore, they are useful as drugs such as remedies for glaucoma and ocular hypertension.
priorityDate 2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H059197-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230673366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231659411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231659313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9870572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68290386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11210971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686

Total number of triples: 36.